Literature DB >> 19689616

Differences in medical treatment of chronic coronary heart disease patients according to medical specialities.

Alberto Cordero1, Vicente Bertomeu-Martínez, Pilar Mazón, Juan Quiles, Joaquín Aznar, Héctor Bueno.   

Abstract

Coronary heart disease (CHD) patients are currently attended by many different medical specialities. CHD patients must achieve the highest grade of treatment implementation and risk factors control. The aims were to describe differences in medical treatment of CHD according to the medical specialities. For this purpose we conducted an observational, cross-sectional, and multicenter study of CHD patients attended by internal medicine (IM), outpatient clinic cardiologist (OCC), hospital cardiologist (HC), and general practitioners (PC). Burden of noncardiac diseases was evaluated by the Charlson index. Joint prescription of antiplatelets, statins, beta-blockade agents and blockade of the renin-angiotensin system by angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptors blockers (ARB) was considered optimal medical treatment (OMT). A total of 2987 patients, mean age 67.4 (11.5) years and 71.5% males, were analyzed. Patients visited by IM physicians had slightly higher mean age and higher prevalence of hypertension, diabetes, and noncardiac diseases (median Charlson index 3.0, 1.0-5.0, vs. 2.0, 1.0-4.0, of total sample). OMT was prescribed in 25.9% (95% CI 25.6-26.2) of the patients and was statistically more frequently carried out by HC (32.1%) and OCC (29.0%) compared to IM (22.0%) and PC practitioners (21.5%). Multivariate analysis showed an independent association between OMT prescription and HC (OR 1.42; 95% CI 1.08-1.87) or OCC (OR 1.31; 95% CI 1.04-1.67); this association remained after including the Charlson index. Noncardiac diseases are the main clinical differences in CHD patients visited by different medical specialist although it does not explain the higher prescription of OMT by cardiologist.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19689616     DOI: 10.1111/j.1755-5922.2009.00093.x

Source DB:  PubMed          Journal:  Cardiovasc Ther        ISSN: 1755-5914            Impact factor:   3.023


  3 in total

1.  Determinants of variations in initial treatment strategies for stable ischemic heart disease.

Authors:  Maria C Bennell; Feng Qiu; Kori J Kingsbury; Peter C Austin; Harindra C Wijeysundera
Journal:  CMAJ       Date:  2015-05-19       Impact factor: 8.262

2.  Patients with cardiac disease: Changes observed through last decade in out-patient clinics.

Authors:  Alberto Cordero; Vicente Bertomeu-Martínez; Pilar Mazón; Lorenzo Fácila; Juan Cosín; Vicente Bertomeu-González; Moisés Rodriguez; Eva Andrés; Enrique Galve; Iñaki Lekuona; Jose R González-Juanatey
Journal:  World J Cardiol       Date:  2013-08-26

3.  Should health insurers target prevention of cardiovascular disease? A cost-effectiveness analysis of an individualised programme in Germany based on routine data.

Authors:  Majed Aljutaili; Christian Becker; Sabine Witt; Rolf Holle; Reiner Leidl; Michael Block; Johannes Brachmann; Sigmund Silber; Kurt Bestehorn; Björn Stollenwerk
Journal:  BMC Health Serv Res       Date:  2014-06-17       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.